Sector: Chemicals & Materials
Industry: Specialty Chemicals / Performance Chemicals / Material Science / Agrochemicals
Status: Private, Unlisted Company
CIN: U24230TG1996PTC025914
Incorporated: 9 December 1996
Headquarters: Hyderabad, Telangana
Promoter / Sponsor: Bain Capital
FY2025 Operating Income: ₹1,298.05 Cr
FY2025 PAT: ₹156.76 Cr
FY2025 PAT Margin: 12.08%
Credit Rating: CRISIL A/Stable / CRISIL A1
Company Overview
Novopor Advanced Science Private Limited is an Indian specialty chemicals and materials science company focused on performance chemicals, material science and agrochemicals.
The company operates as a development and manufacturing partner, providing solutions ranging from R&D, route scouting and process development to commercial-scale manufacturing.
Novopor is backed by Bain Capital and has been expanding its specialty-chemicals platform through acquisitions and investments in advanced manufacturing capabilities. The company operates manufacturing facilities in India and has been expanding its international footprint through acquisitions in the US.
The company’s registered corporate identity is Novopor Advanced Science Private Limited, while the business was historically associated with Porus Laboratories.
Company Snapshot
| Particular | Details |
|---|---|
| Company | Novopor Advanced Science Private Limited |
| CIN | U24230TG1996PTC025914 |
| Incorporation | 9 December 1996 |
| Status | Unlisted Private Company |
| Registered Office | Shaikpet, Telangana |
| Industry | Chemicals & Materials |
| Business | Specialty Chemicals & Material Science |
| Major Segments | Performance Chemicals, Material Science, Agrochemicals |
| FY25 Operating Income | ₹1,298.05 Cr |
| FY25 PAT | ₹156.76 Cr |
| FY25 PAT Margin | 12.08% |
| FY25 Adjusted Debt / Net Worth | 0.29x |
| FY25 Interest Coverage | 13.69x |
| Credit Rating | CRISIL A/Stable; CRISIL A1 |
| Paid-up Capital | ~₹7.39 Cr |
| Listing Status | Unlisted |
Financial and corporate information is based on CRISIL Ratings and publicly available company/MCA-derived information.
What Does Novopor Do?
Novopor operates across three major business segments:
1. Performance Chemicals
The company develops and manufactures specialty chemicals used in areas such as:
- Electronic chemicals
- Coatings
- Adhesives
- Sealants
- Elastomers
- Flavours & fragrances
- Cosmetic chemicals
These products are used across industrial and consumer applications.
2. Material Science
Novopor manufactures specialty monomers, polymers and polymer additives.
Its material-science portfolio serves industries including:
- Automotive
- Electronics
- Aerospace
- Medical
- Construction
- Packaging
- Adhesives
- Industrial applications
The company highlights 25+ advanced product lines, six dedicated plants and 50 experienced R&D professionals in its material-science business.
3. Agrochemicals
Novopor develops and manufactures intermediates used in the production of:
- Fungicides
- Insecticides
- Herbicides
The company positions itself as a development and manufacturing partner for agrochemical companies.
Advanced Chemistry Capabilities
A key differentiator of Novopor is its ability to handle complex chemistry at commercial scale.
The company’s capabilities include:
- Grignard reactions
- Catalytic reactions
- Oxidation
- Chlorination
- Nitration
- Flow chemistry
- Polymer chemistry
- Biotechnology
- High-pressure chemistry
- Vapour-phase chemistry
Novopor states that its capabilities span from laboratory-scale proof of concept to multi-metric-ton commercial production.
End-Market Exposure
Novopor serves multiple high-value industrial markets.
| Market | Applications |
|---|---|
| Agrochemicals | Fungicide, insecticide & herbicide intermediates |
| Electronics | Semiconductor, PCB & battery chemicals |
| Specialty Polymers | Monomers, polymers & additives |
| Automotive | Advanced materials and performance chemicals |
| Aerospace | Specialty materials and chemicals |
| Coatings | Coatings, adhesives & sealants |
| Construction | Performance materials |
| Consumer Chemicals | Flavours, fragrances & cosmetics |
| Industrial Chemicals | Specialty intermediates |
This diversification gives Novopor exposure to several industrial value chains rather than relying on a single end market.
Manufacturing Footprint
Novopor operates advanced manufacturing facilities in India.
The company’s capabilities page identifies two advanced plants inside the SEZ in Vizag, with a new facility being developed at Dahej, Gujarat.
Novopor also inaugurated a new pilot plant facility at its Vizag Unit-01 SEZ facility in September 2025, strengthening its R&D and scale-up capabilities.
The company states that its manufacturing infrastructure is designed to provide scalable production and stringent quality control for global customers.
History & Evolution
Key Milestones
1994 — Novopor’s business roots trace back to the establishment of its specialty-chemicals operations.
1998 — Started supporting domestic manufacturers.
1999 — Added R&D capabilities.
2006 — Expanded into specialty chemicals through acquisition and in-house R&D.
2014 — Further expanded into high-performance specialty chemicals.
2018 — Expanded its specialty-chemicals manufacturing capabilities.
2019 — Expanded into specialty and agrochemical capabilities through a global agrochemical partnership.
2023 — Bain Capital acquired the specialty and agrochemical business of Porus.
2025 — Novopor acquired Pressure Chemical Company in the US, strengthening its high-pressure and specialty chemistry capabilities.
2026 — Novopor acquired FAR Chemical in the US, expanding its presence in electronics, aerospace & defence, coatings, adhesives and specialty chemicals.
Financial Performance
CRISIL’s latest rating rationale provides the following financial information:
| ₹ Crore | FY23 | FY24 | FY25 |
|---|---|---|---|
| Operating Income | 1,069.79 | 762.87 | 1,298.05 |
| PAT | 48.36 | 79.74 | 156.76 |
| PAT Margin | 4.52% | 10.45% | 12.08% |
| Adjusted Debt / Net Worth | 0.81x | 0.42x | 0.29x |
| Interest Coverage | 6.10x | 7.53x | 13.69x |
Source: CRISIL Ratings.
FY25 Performance Analysis
FY2025 was a strong year for Novopor.
Operating income increased from ₹762.87 Cr in FY24 to ₹1,298.05 Cr in FY25, representing growth of approximately 70%.
PAT increased from ₹79.74 Cr to ₹156.76 Cr, representing growth of approximately 97%.
At the same time, PAT margin improved from 10.45% to 12.08%.
The improvement in profitability alongside revenue growth indicates stronger operating performance during FY25.
Balance Sheet & Credit Profile
Novopor’s credit profile improved materially during FY25.
Adjusted debt-to-net-worth declined from:
0.81x in FY23 → 0.42x in FY24 → 0.29x in FY25
Interest coverage also improved:
6.10x in FY23 → 7.53x in FY24 → 13.69x in FY25
This indicates stronger debt-servicing capacity based on the metrics reported by CRISIL.
Credit Rating
In May 2026, CRISIL upgraded Novopor’s bank-facility ratings to:
CRISIL A / Stable
Long-Term Rating
CRISIL A1
Short-Term Rating
The total bank facilities rated were approximately ₹609 Cr.
CRISIL stated that the upgrade reflected sustained improvement in Novopor’s credit-risk profile, driven by healthy operating performance and a comfortable financial-risk profile.
Bain Capital Backing
Novopor is a Bain Capital portfolio company.
Bain Capital’s involvement provides institutional sponsorship as Novopor builds a larger specialty-chemicals platform through organic investments and acquisitions.
The company has pursued a strategy of combining advanced chemistry capabilities with scalable manufacturing and international expansion.
International Expansion
One of the major developments for Novopor has been its expansion outside India.
Pressure Chemical Company
In May 2025, Novopor announced the acquisition of Pressure Chemical Company, a Pittsburgh-based specialist in high-pressure and specialty chemistry.
The acquisition was aimed at strengthening Novopor’s development-to-scale capabilities and adding high-pressure chemistry expertise.
FAR Chemical
In January 2026, Novopor announced the acquisition of FAR Chemical, a US-based specialty chemical manufacturer.
FAR Chemical serves areas including:
- Electronics
- Aerospace & Defence
- Coatings & Adhesives
- Specialty Chemicals
The acquisition expands Novopor’s US footprint and adds complex chemistry capabilities to its global platform.
R&D and Innovation
R&D is an important component of Novopor’s business model.
The company operates an Innovation Centre in Hyderabad and has been expanding its pilot-scale capabilities.
Its R&D and manufacturing platform is designed to support the full journey from:
Discovery → Route Development → Scale-Up → Commercial Manufacturing
The company also highlights advanced analytical laboratories and quality-control infrastructure at its manufacturing facilities.
Competitive Strengths
1. Complex Chemistry Capabilities
Novopor has capabilities across advanced and hazardous chemistries, including high-pressure, flow, catalytic, oxidation, chlorination and nitration reactions.
2. R&D-Driven Business Model
The company works with customers from early-stage development through commercial manufacturing, creating potential for long-term customer relationships.
3. Diversified End Markets
Exposure to agrochemicals, electronics, polymers, coatings, adhesives, aerospace and other applications reduces reliance on a single market.
4. Institutional Backing
Bain Capital’s ownership provides institutional sponsorship and supports Novopor’s acquisition-led expansion strategy.
5. International Expansion
The acquisitions of Pressure Chemical and FAR Chemical have expanded Novopor’s geographic footprint and technical capabilities.
6. Improving Financial Profile
FY25 showed substantial growth in revenue and PAT, accompanied by improved leverage and interest coverage.
Key Growth Drivers
Specialty Chemicals
Increasing demand for differentiated chemicals and advanced materials can provide opportunities for Novopor’s development and manufacturing platform.
Electronics & Semiconductor Chemicals
Novopor identifies electronic chemicals as one of its served markets, including chemicals used in semiconductor fabrication, PCBs and battery applications.
Specialty Polymers
Demand for high-performance polymers and additives across automotive, electronics, aerospace and industrial applications provides another potential growth area.
Agrochemical Intermediates
The company has established capabilities in developing and manufacturing intermediates for fungicides, insecticides and herbicides.
Global Expansion
The acquisitions in the US provide Novopor with access to new customers, capabilities and end markets.
Key Risks
1. Chemical Industry Cyclicality
Specialty and performance chemical businesses can be affected by changes in global demand, inventory cycles and customer destocking.
2. Raw Material Price Volatility
Changes in the prices and availability of chemical raw materials can affect manufacturing costs and margins.
3. Regulatory & Environmental Risk
Chemical manufacturing involves stringent environmental, safety and regulatory requirements. Non-compliance or operational incidents could affect business performance.
4. Acquisition Integration Risk
Novopor has adopted an acquisition-led international expansion strategy. Integrating acquired businesses, systems, employees and customers can create execution challenges.
5. Customer Concentration
Specialty chemical manufacturers can have significant exposure to large customers, particularly where products are developed specifically for individual applications.
6. Unlisted Liquidity
Novopor is privately held and its shares are not traded on NSE or BSE. Unlisted shares can therefore have substantially lower liquidity and price discovery compared with listed securities.
IPO / Listing Status
Novopor Advanced Science Private Limited is currently an unlisted private company.
I could not verify a current SEBI DRHP or formal IPO timetable from reliable primary sources. Therefore, any claim regarding a confirmed IPO date, issue size or expected listing valuation should be treated as unverified unless supported by an official filing.
Important Valuation Point
For an unlisted investor, Novopor should not be valued only on revenue growth.
Key valuation factors include:
- Latest audited FY25/FY26 financial statements
- EBITDA and PAT growth
- Cash-flow generation
- Net debt
- Return on capital
- Bain Capital’s ownership structure
- Number of outstanding shares
- Recent private-market transactions
- Acquisition impact
- International business contribution
- IPO / strategic-event possibility
- Liquidity discount
- Comparable specialty chemical companies
The company’s recent acquisitions also mean that investors should understand whether the valuation reflects the existing Indian business, acquired overseas businesses, or the combined global platform.
Investment Snapshot
| Parameter | Observation |
|---|---|
| Business | Specialty Chemicals & Material Science |
| Industry | Specialty / Performance Chemicals |
| Main Segments | Performance Chemicals, Material Science, Agrochemicals |
| FY25 Operating Income | ₹1,298.05 Cr |
| FY25 PAT | ₹156.76 Cr |
| FY25 PAT Margin | 12.08% |
| FY25 Adjusted Debt / Net Worth | 0.29x |
| FY25 Interest Coverage | 13.69x |
| Credit Rating | CRISIL A / Stable; A1 |
| Manufacturing | Vizag, India; expansion at Dahej |
| R&D | Hyderabad Innovation Centre |
| Sponsor | Bain Capital |
| Recent Acquisitions | Pressure Chemical Company; FAR Chemical |
| Listing | Unlisted |
| IPO | No verified current DRHP identified |
UnlistedCart Takeaway
Novopor Advanced Science represents a specialty-chemicals and advanced-materials platform rather than a conventional commodity chemical manufacturer.
The company has exposure to performance chemicals, material science, agrochemicals, specialty polymers and electronic chemicals, while its capabilities extend from R&D and process development to commercial-scale manufacturing.
FY2025 was a strong financial year, with operating income rising to approximately ₹1,298 Cr and PAT reaching ₹156.76 Cr. At the same time, the company’s reported adjusted debt-to-net-worth ratio declined to 0.29x, while interest coverage improved to 13.69x.
The Bain Capital backing, expansion into advanced chemistry, new manufacturing investments and acquisitions of Pressure Chemical Company and FAR Chemical have transformed Novopor into a broader international specialty-chemicals platform.
For unlisted investors, however, the entry valuation, share price, liquidity, ownership structure and the financial contribution of recent acquisitions remain important factors to examine before evaluating the shares.
Important Links
Official Website:
Novopor Advanced Science
About the Company:
Novopor — About & History
Business Segments:
Novopor — Business Segments & Capabilities
Material Science:
Novopor — Material Science
Company Documents:
Novopor — Documents & Resources
FY25 Sustainability Report:
Novopor Annual Sustainability Report FY2024-25
CRISIL Rating:
CRISIL — Novopor Advanced Science Rating Rationale, May 2026
Corporate Information:
Novopor Advanced Science — Company Details
Disclaimer
This report is prepared solely for informational and educational purposes and should not be construed as investment advice, an offer to buy or sell securities, or a recommendation to invest in Novopor Advanced Science Private Limited.
Unlisted securities can involve high liquidity risk, limited price discovery, limited publicly available information, valuation risk and transfer restrictions. Financial information has been compiled from publicly available company disclosures, credit-rating reports and corporate databases. Figures may differ depending on accounting classification, standalone/consolidated treatment and subsequent filings.
Investors should independently verify the latest audited financial statements, MCA filings, shareholding pattern, outstanding charges, transaction price, valuation, number of shares outstanding and transferability before making any investment decision.
For more such unlisted stocks visit UnlistedCart – Unlisted Shares
